Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee debates psychedelic‑assisted therapy pilot for veterans; sponsors say bill preserves ongoing research
Summary
Lawmakers discussed SB191, a time‑limited pilot designed to prevent enrolled veterans from losing access to psychedelic‑assisted therapies if FDA approval proceeds; members praised the potential benefits but asked whether state programs should intervene before FDA processes conclude.
The committee took up Senate Bill 191, which sponsors described as narrowly aimed at preserving ongoing pilot research for veterans and others enrolled in clinical programs for severe PTSD or depression. Chair (S5) said the bill does not legalize drugs or create new approvals — rather, it prevents enrolled participants from losing access to treatment if an FDA approval or regulatory change would otherwise stop the study.
Representative Mara (S13) and Senator Summers (S11) expressed concern about the interplay between state‑funded pilots and the national…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
